PIXELCELL PTE.LIMITED – Trademark Portfolio
Entity Type: 99
PIXELCELL PTE.LIMITED holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 16 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 8 trademarks are registered and 8 are pending. Notable registered marks include BEVOCAL, GRADEUP, MINDBUD, NOTEMAX, and YARNPAL. The owner is based in SINGAPORE.
ROYAL GROUP BUILDING
3 PHILLIP STREET#09-02
SINGAPORE 048693 , SG
Showing of trademarks Trademarks
Trademark Classifications
PIXELCELL PTE.LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does PIXELCELL PTE.LIMITED have?
PIXELCELL PTE.LIMITED has 17 U.S. trademarks filed with the USPTO. Of these, 8 registered, 8 pending, 1 abandoned.
What trademark classes does PIXELCELL PTE.LIMITED file in?
PIXELCELL PTE.LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are PIXELCELL PTE.LIMITED's most well-known trademarks?
PIXELCELL PTE.LIMITED's registered trademark portfolio includes well-known marks such as BEVOCAL, GRADEUP, MINDBUD, NOTEMAX, and YARNPAL. These are among 8 currently registered trademarks in the portfolio.
What is PIXELCELL PTE.LIMITED's trademark registration success rate?
PIXELCELL PTE.LIMITED has a 89% trademark registration rate, with 8 out of 9 resolved applications resulting in successful registration. Currently, 8 applications are pending review.